Site Members can sign up for company wide alerts
Lawsuit Overview
March 27, 2025 - An investor in shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Actinium Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between October 31, 2022, and August 2, 2024. New York base...
You must register (for free) or login to view the entire case.